ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1786 • ACR Convergence 2022

    Anterior Knee Pain Is Associated with 2-year Compartment Specific Patellofemoral Cartilage Worsening: The MOST Study

    Corey Lanois1, Natalie Collins2, Tuhina Neogi3, Ali Guermazi4, Frank Roemer5, Michael LaValley6, Michael Nevitt7, James Torner8, Cora E. Lewis9 and Joshua Stefanik10, 1Northeastern University, Providence, RI, 2University of Queensland, Brisbane, Australia, 3Boston University School of Medicine, Boston, MA, 4Boston University, Boston, MA, 5Friedrich-Alexander University Erlangen Nürnberg, Erlangen, Germany, 6Boston University School of Public Health, Arlington, MA, 7University of California at San Francisco, Orinda, CA, 8University of Iowa, Iowa City, IA, 9University of Alabama at Birmingham, Birmingham, AL, 10Northeastern University, Boston, MA

    Background/Purpose: Anterior knee pain (AKP) may be a precursor to patellofemoral osteoarthritis (PFOA). Cross-sectionally, frequent AKP has been associated with MRI features of PFOA; however,…
  • Abstract Number: 1777 • ACR Convergence 2022

    A Symptom Checker App Is Better at Classifying Inflammatory Disease Than Physicians Who Are Presented Identical Information

    markus Gräf1, Johannes Knitza2, Jan Leipe3, Martin Krusche4, Martin Welcker5, Sebastian Kuhn6, Johanna Mucke7, Axel Hueber8, Johannes Hornig9, Philipp Klemm10, stefan Kleinert11, Peer Aries12, Nicolas Vuillerme13, Arnd Kleyer2, Georg Schett14 and Johanna Callhoff15, 1Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 3Division of Rheumatology, Department of Medicine V, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany, 4University Hospital Hamburg-Eppendorf, Hamburg, Germany, 5GBR, Planegg, Germany, 6Department of Digital Medicine, Medical Faculty OWL, Bielefeld University, Bielefeld, Germany, 7Policlinic and Hiller Research Center, Heinrich-Heine-University Duesseldorf, Neuss, Germany, 8Paracelsus University Nürnberg, Erlangen, Germany, 9Rheumatologische Schwerpunktpraxis, Osnabrück, Germany, 10Campus Kerckhoff of Justus Liebig University Giessen, Bad Nauheim, Germany, 11Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN), Erlangen, Germany, 12Rheumatologie im Struenseehaus, Hamburg, Germany, 13Université Grenoble Alpes, AGEIS, Grenoble, France, 14Universitätsklinikum Erlangen, Erlangen, Germany, 15German Rheumatism Research Centre, Berlin, Germany

    Background/Purpose: The purpose of this study was to compare the ability of an artificial intelligence-based symptom checker app (Ada) and physicians to determine the presence/absence…
  • Abstract Number: 1788 • ACR Convergence 2022

    Pulmonary Vascular Dysfunction Occurs in Association with Hyperuricaemia: Assessment by a Novel Non-Invasive Measurement of Pulmonary Pulse Wave Transit Time

    Rachael Flood1, Nicole Fagan2, Diarmuid O'Brien1, Colm Kirby1, David Kane1 and Ronan Mullan1, 1Tallaght University Hospital, Dublin, Ireland, 2St James' Hospital, Dublin, Ireland

    Background/Purpose: Hyperuricaemia is common in pulmonary hypertension (PH) occurring in up to 80% of patients with serum uric acid levels(sUA) correlating with poor PH outcomes.…
  • Abstract Number: 1792 • ACR Convergence 2022

    Contemporary Racial/Ethnic Disparities in Emergency Department Visits and Hospitalizations for Gout in the United States – 2019 Nationwide Analysis

    Chio Yokose1, natalie mccormick2, na lu3, amit johi4, Lesley Jackson5, Minna Kohler6, Janeth Yinh2, yuqing zhang7, John Hsu2, kenneth saag5 and Hyon Choi8, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Arthritis Research Canada, Boston, MA, 4Regeneron, Boston, MA, 5University of Alabama at Birmingham, Birmingham, AL, 6Massachusetts General Hospital, Harvard Medical School, Boston, MA, 7Massachusetts General Hospital, Quincy, MA, 8MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: Gout is a highly prevalent inflammatory arthritis with increasing global disease burden in recent years.1,2 A recent analysis3 of the Multiethnic Cohort Study reported…
  • Abstract Number: 1790 • ACR Convergence 2022

    Ultrasound Diagnosis of Calcium Pyrophosphate Crystal Deposition: Which Sites Should Be Scanned?

    Edoardo Cipolletta1, Erica Moscioni2, Silvia Sirotti3, Georgios Filippou4 and Emilio Filippucci5, 1Polytechnic University of Marche, Ancona, Italy, 2Polytechnic University of Marche, Jesi, Italy, 3Università degli Studi di Milano, Milano, Italy, 4Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy, 5Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Italy

    Background/Purpose: In recent years, ultrasonography (US) has emerged as an accurate and reliable tool for the diagnosis of calcium pyrophosphate (CPP) deposition disease (CPPD) in…
  • Abstract Number: 1795 • ACR Convergence 2022

    Therapeutic Strategies for Patients with Chronic Manifestations of Calcium Pyrophosphate Deposition Disease

    Julien Damart1, Silvia Sirotti2, Mariano Andrès3, Edoardo Cipolletta4, Georgios Filippou5, Davide Carboni6, Emilio Filippucci7, Pilar Diez8, Abhishek Abhishek9, Augustin Latourte10, Hang-Korng Ea11, Sebastien Ottaviani12, Jean-Guillaume Letarouilly13, Renaud Desbarbieux14, Sahara Graf1, Laurène Norberciak1, Pascal Richette15 and Tristan Pascart16, 1Hôpital Saint-Philibert, Lomme, France, 2Università degli Studi di Milano, Milano, Italy, 3Dr Balmis Alicante General University Hospital-ISABIAL, Alicante, Spain, 4Polytechnic University of Marche, Ancona, Italy, 5Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy, 6Luigi Sacco University, Milano, Italy, 7Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi, Italy, 8Alicante University, Alicante, Spain, 9University of Nottingham, Nottingham, United Kingdom, 10Université de Paris, Paris, France, 11Lariboisière Hospital, Paris, France, 12Hopital Bichat-Claude Bernard, Paris, France, 13CHU Lille, Lille, France, 14Ch Boulogne-sur-Mer, Boulogne-sur-Mer, France, 15Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France, 16Groupement Hospitalier de l'Institut Catholique de Lille, Lomme, France

    Background/Purpose: Calcium pyrophosphate deposition (CPPD) disease lacks recommendations on treatment strategies. This study reports on treatment modalities used in European tertiary hospitals for the management…
  • Abstract Number: 1794 • ACR Convergence 2022

    Characteristics of Patients with Repeat Visits for Acute Gout at a University Hospital Emergency Department

    David Lim1, Manushi Aggarwal1 and Marven Cabling2, 1Loma Linda University Health, Redlands, CA, 2Loma Linda University, REDLANDS, CA

    Background/Purpose: Gout is the most common inflammatory arthritis in adults that results in high disease burden and health care utilization. The objective of the study…
  • Abstract Number: 1787 • ACR Convergence 2022

    The Impact of Topically Applied pH Modulator on Acute Inflammatory Pain, Serum Calcium, and C-Reactive Protein (CRP) During an Acute Gout Flare – a Phase 2a Randomized, Double-Blind, Placebo-Controlled Study

    Puja Khanna1 and Ryan Beal2, 1University of Michigan, Ann Arbor, MI, 2Dyve Biosciences, Inc, Camarillo, CA

    Background/Purpose: Inflammatory cytokine-mediated bone resorption increases serum calcium (Ca2+) and can lead to calcification at chronically inflamed sites. Ca2+ influences cytokine activity to intensify the…
  • Abstract Number: 1775 • ACR Convergence 2022

    More Than Half of Patients with Osteoarthritis Have Positive Screening for Fibromyalgia And/or Depression, Feasibly Assessed in Routine Care on Indices Within a Single MDHAQ (multidimensional Health Assessment Questionnaire)

    Theodore Pincus1, Kathryn Gibson2, Juan Schmukler1, Tengfei Li3 and Joel Block1, 1Rush University Medical Center, Chicago, IL, 2Liverpool Hospital, Sydney, Australia, 3Georgetown University, Washington, DC

    Background/Purpose: Osteoarthritis (OA) patients may have widely divergent scores for pain severity vs X-ray joint damage, indicating that elevated OA pain 0-10 visual numeric scale…
  • Abstract Number: 1799 • ACR Convergence 2022

    Evaluation of Adherence to and Agreement with the 2020 American College of Rheumatology Guideline for the Management of Gout by US Rheumatologists

    Naomi Schlesinger1, Michael Pillinger2 and Peter Lipsky3, 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 2NYU Grossman School of Medicine, New York, NY, 3AMPEL BioSolutions, Charlottesville, VA

    Background/Purpose: The American College of Rheumatology (ACR) developed an updated guideline in 2020 for the management of gout.1 This study evaluates US rheumatologists' stated adherence…
  • Abstract Number: 1798 • ACR Convergence 2022

    Health-Related Quality of Life Improvements Resulting from a Treat-to-Target Strategy in the Management of Gout: Post- Hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial

    Lindsay Helget1, James O'Dell1, Jeff Newcomb1, Maria Androsenko2, Mary Brophy2, Anne Davis-Karim3, Bryant England1, Ryan Ferguson2, Michael Pillinger4, Tuhina Neogi5, Paul Palevsky6, Hongsheng Wu2 and Ted Mikuls7, 1University of Nebraska Medical Center, Omaha, NE, 2VA Boston Cooperative Studies Program Coordinating Center, Boston, MA, 3VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, 4NYU Grossman School of Medicine, New York, NY, 5Boston University School of Medicine, Boston, MA, 6University of Pittsburgh School of Medicine, Pittsburgh, Pittsburgh, 7Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: The ACR recommends a treat-to-target strategy in gout management, centered on the titration of urate lowering therapy (ULT) to a goal serum urate (SU)…
  • Abstract Number: 1802 • ACR Convergence 2022

    The Utility of Dual-energy Computed Tomography in Gout Patients During Urate Lowering Therapy

    Min Jung Kim1, Mi Hyeon Kim2, SE RIM CHOI2, Youjin Jung2, Ji In Jung2, Ju Yeon Kim2, Jee Won Chai3 and Kichul Shin4, 1Seoul Metropolitan Government Boramae Medical center, Dongjak-gu, Seoul, Republic of Korea, 2Seoul National University Hospital, Seoul, Republic of Korea, 3Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Republic of Korea, 4Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, Republic of Korea

    Background/Purpose: To investigate whether monosodium urate (MSU) deposition measured by dual-energy computed tomography (DECT) could help predict acute flares after discontinuing colchicine prophylaxis in patients…
  • Abstract Number: 1801 • ACR Convergence 2022

    High Frequency of Structural Damage in the Lower Spine of Patients with Chondrocalcinosis

    Kalliopi Klavdianou1, Jona Kasfeld2, Martin Fruth3, Styliani Tsiami4, Juergen Braun5, Philipp Sewerin6, David Kiefer5 and Xenofon Baraliakos7, 1'Asklepieion' General Hospital, Department of Rheumatology, Voula, Athens, Greece, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3Blikk, Radiologie, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany, 6Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 7Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Calcium pyrophosphate dihydrate crystal deposition disease (CPPD, chondrocalcinosis) is known to affect fibrocartilaginous tissue in the large and smaller peripheral joints. The affection of…
  • Abstract Number: 1774 • ACR Convergence 2022

    Performance of an Early Triage System for Identification of Patients with Inflammatory Rheumatic Diseases

    Xenofon Baraliakos1, Imke Redeker2, Maria Zacharopoulou2, Styliani Tsiami3 and Juergen Braun4, 1Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Herne, Ruhr-University Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: The preselection of patients with suspicion of an inflammatory rheumatic disease is not easy for general practitioners and orthopedists. In countries with a limited…
  • Abstract Number: 1725 • ACR Convergence 2022

    Sex Differences in Autoimmune Pathogenesis and Systemic Response to High Fat Diet in Lupus-prone Mice

    Gitanjali Lobo1, Juan Meng2, Xuhua Shi2, Ronak Patel3, Laura Rivers4, Chad Hille5, Robert Quinet6, William Davis7, Jerald Zakem8, Chandana Keshavamurthy9, Tamika Webb-Detiege10, Zongbing You2 and Xin Zhang11, 1Ochsner Clinic Foundation, Metairie, LA, 2Tulane University, New Orleans, LA, 3Ochsner, New Orleans, LA, 4Ochsner Medical Center, River Ridge, LA, 5Ochsner Clinic Foundation, New Orleans, LA, 6Ochsner Health, River Ridge, LA, 7Ochsner Medical Center, New Orleans, LA, 8Ochsner Health Systems, Metairie, LA, 9ochsner medical center, Metairie, LA, 10University of Queensland/Ochsner Clinical School, New Orleans, LA, 11Institution of Translational Research, Ochsner Health System, New Orleans, LA

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by chronic inflammation and the production of autoantibodies, leading to systemic multiorgan damage. SLE has…
  • « Previous Page
  • 1
  • …
  • 658
  • 659
  • 660
  • 661
  • 662
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology